A Study of the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease A Study of the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Cr ...
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Assess the Efficacy a ...